Literature DB >> 31558238

Rapid Postoperative Relapse in ALK-Positive Locally Advanced NSCLC Patient with Complete Pathological Response to Neoadjuvant Crizotinib.

Chao Zhang1, Yi-Long Wu2, Wen-Zhao Zhong3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31558238     DOI: 10.1016/j.jtho.2019.05.036

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  1 in total

1.  Pathological complete response to neoadjuvant ceritinib of a crizotinib-resistant, stage IIIB non-small cell lung cancer with ALK rearrangement: A case report.

Authors:  Zhongxing Bing; Ziqi Jia; Yadong Wang; Jianchao Xue; Lei Cao; Zhili Cao; Peng Liu; Ji Li; Naixin Liang; Shanqing Li
Journal:  Thorac Cancer       Date:  2021-06-09       Impact factor: 3.500

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.